Literature DB >> 16907656

Side effects of using nitrates to treat angina.

Udho Thadani1, Tiffany Rodgers.   

Abstract

Nitrates are very effective antianginal and anti-ischaemic agents. Provision of a long nitrate-free interval or low plasma nitrate levels prior to the morning dose prevents the loss of clinical efficacy by preventing the development of tolerance. However, side effects during nitrate therapy are common. Headache is the most common side effect of nitrates; often dose-related and reported by up to 82% of patients in placebo-controlled trials. Nearly 10% of patients are unable to tolerate nitrates due to disabling headaches or dizziness. In others, headaches are mild-to-moderate in severity and either resolve or diminish in intensity with continued nitrate therapy. Nitrate-induced hypotension is common, but often asymptomatic. In rare instances, nitrate-induced hypotension is severe and accompanied by marked slowing of the heart rate and syncope. Use of nitrates in patients who experience syncope after administration of nitrates is contraindicated. Nitrates rarely cause coronary steal and myocardial ischaemia. Nitrate rebound may occur and patients may experience nocturnal anginal episodes during intermittent therapy with nitroglycerin patches. Administration of nitrates is contraindicated with concomitant use of phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction, as combination therapy may lead to profound hypotension and even death. There are disturbing observational reports in the literature that continuous, prolonged use of nitrates may lead to increased mortality and recurrent myocardial infarctions. Large, randomised, placebo-controlled studies are needed to confirm or refute these reports; until then, the use of nitrates to treat angina is here to stay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907656     DOI: 10.1517/14740338.5.5.667

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  18 in total

Review 1.  Paradoxical and bidirectional drug effects.

Authors:  Silas W Smith; Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

Review 2.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

3.  Sivelestat relaxes vascular smooth muscle contraction in human gastric arteries.

Authors:  Hiroko Amemori; Yoshinori Maeda; Arisu Torikai; Mikio Nakashima
Journal:  J Physiol Biochem       Date:  2011-07-14       Impact factor: 4.158

Review 4.  [National disease management guidelines (NVL) for chronic CAD : What is new, what is particularly important?].

Authors:  K Werdan
Journal:  Herz       Date:  2016-09       Impact factor: 1.443

Review 5.  Practical instructions for using drugs in CT and MR cardiac imaging.

Authors:  Giuseppe Rovere; Agostino Meduri; Giancarlo Savino; Francesco Ciriaco Flammia; Francesca Lo Piccolo; Maria Rachele Pia Carafa; Anna Rita Larici; Luigi Natale; Biagio Merlino; Riccardo Marano
Journal:  Radiol Med       Date:  2020-08-24       Impact factor: 3.469

6.  Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells.

Authors:  Norika Mengchia Liu; Kin Lung Siu; Ji Youn Youn; Hua Cai
Journal:  J Mol Med (Berl)       Date:  2016-12-21       Impact factor: 4.599

Review 7.  Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Eur Cardiol       Date:  2018-08

8.  Alpha-crystallin: an ATP-independent complete molecular chaperone toward sorbitol dehydrogenase.

Authors:  I Marini; R Moschini; A Del Corso; U Mura
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

Review 9.  Syncope and Headache.

Authors:  Ramesh K Khurana
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

10.  Ivabradine: the evidence of its therapeutic impact in angina.

Authors:  Guillaume Marquis-Gravel; Jean-Claude Tardif
Journal:  Core Evid       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.